NEW YORK, Dec. 26 - Sequencing the human genome was widely expected to produce a wealth of new drug targets, and the genomics startups that burst onto the scene in recent years have largely delivered. As a result, the research market for genomics companies is vibrant: Worth just $2 billion two years ago, the market is poised to reach $8 billion by 2004, the need for better technology and marketable drugs and diagnostics fueling the growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.